Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Circulating Tumour Cell Molecular Diagnostics Using a Novel Microfluidic Device

NCT01193829 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT01193829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01193829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Circulating Tumour Cell Molecular Diagnostics Using a Novel Microfluidic Device
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2010
Completion date
December 31, 2014
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with non-small cell lung cancer